TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17473911

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100,000 IU ergocalciferol every four months)
Number of subjects: 3440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3440

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 3440
Study: 15878442

Group type: EXPERIMENTAL
Intervention: telithromycin 800 mg qd for 7-10 days
Number of subjects: 115
Study: 12495265

Group type: EXPERIMENTAL
Intervention: 20 mg curcumin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg curcumin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 80 mg curcumin
Number of subjects: 12
Study: 9802626

Group type: EXPERIMENTAL
Intervention: Azithromycin for 5 days
Number of subjects: 420

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate or erythromycin for 10 days (control)
Number of subjects: 420
Study: 7706609

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (150 mg/day for 1 week, followed by 300 mg/day for 3 weeks)
Number of subjects: 8
Study: 2615456

Group type: EXPERIMENTAL
Intervention: Yi‐qi Huo‐xue Injection (YHI)
Number of subjects: 0
Study: 700592

Group type: EXPERIMENTAL
Intervention: Mebeverine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31373782

Group type: EXPERIMENTAL
Intervention: Epicardial delivery of cardiopoietic stem cells (CP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study: 31129105

Group type: EXPERIMENTAL
Intervention: Swallowing disorders (SD)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Bronchopneumonia (BP)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: NIHSS scores >4, involvement of the medulla oblongata, wearing a dental prosthesis
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: NIHSS scores >4, male sex, bilateral cerebral lesions, presence of SD, use of an enteral feeding tube
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Presence of SD
Number of subjects: 340
Study: 27699890

Group type: EXPERIMENTAL
Intervention: Megagen AnyRidge (AR) implant
Number of subjects: 7

Group type: COMPARATOR
Intervention: Megagen EZ Plus Internal (EZ) implant
Number of subjects: 7
Study: 25634244

Group type: EXPERIMENTAL
Intervention: Integrated family planning and HIV services
Number of subjects: 974

Group type: COMPARATOR
Intervention: Standard referral-based system (control)
Number of subjects: 974
Study: 23881185

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50 mg/day
Number of subjects: 2189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2189
Study: 21766512

Group type: EXPERIMENTAL
Intervention: Serum prohepcidin (pHp) levels
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Serum iron (sFe)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Total iron binding capacity (TIBC)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Transferrin saturation
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Ferritin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Zinc-protoporphyrine (ZPP) in erythrocytes
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High sensitivity C-reactive protein (hs-CRP)
Number of subjects: 84
Study: 18848434

Group type: EXPERIMENTAL
Intervention: Standardized capsule of Camellia sinensis (CSC)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 18240698

Group type: EXPERIMENTAL
Intervention: 6-month scholarship to a structured commercial program
Number of subjects: 21

Group type: COMPARATOR
Intervention: Weight management counseling (control)
Number of subjects: 21
Study: 15723941

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injections (4-mg/mL solution, 0.5 mL, once per week for 4 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Isotonic sodium chloride (saline) solution (0.5 mL, once per week for 4 weeks)
Number of subjects: 36
Study: 11880081

Group type: EXPERIMENTAL
Intervention: 15 mL of 1% lidocaine in the lateral and apical periprostatic regions, 5 mL in each point, 10 minutes before the biopsy
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (no lidocaine injection)
Number of subjects: 152
Study: 9667276

Group type: EXPERIMENTAL
Intervention: Postoperative therapy
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Preoperative therapy
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Both preoperative and postoperative therapy
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Intraoperative radiation alone
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Modern radiation treatment techniques
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Clinical trial participation
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Combined modality therapy
Number of subjects: 507
Study: 7640488

Group type: EXPERIMENTAL
Intervention: Reiss Screen for Maladaptive Behavior
Number of subjects: 0
Study: 2565697

Group type: EXPERIMENTAL
Intervention: Metipranolol (Bétanol) eye drops
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Betaxolol (Bétoptic) eye drops
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (physiological saline)
Number of subjects: 12
Study: 321002

Group type: EXPERIMENTAL
Intervention: Bed rest and sedation
Number of subjects: 135

Group type: COMPARATOR
Intervention: Normal activity and non-sedation
Number of subjects: 135
Study: 30601358

Group type: EXPERIMENTAL
Intervention: MC‐PMMA group
Number of subjects: 105

Group type: COMPARATOR
Intervention: PMMA group
Number of subjects: 105
Study: 30400876

Group type: EXPERIMENTAL
Intervention: STROKE-CARD multifaceted post-stroke disease management program
Number of subjects: 2160

Group type: COMPARATOR
Intervention: Usual post-stroke patient care
Number of subjects: 2160
Study: 26496937

Group type: EXPERIMENTAL
Intervention: Prepackaged low-residue diet (PLD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Restricted diet (RD)
Number of subjects: 100
Study: 24513152

Group type: EXPERIMENTAL
Intervention: fMRI-informed EEG source-imaging
Number of subjects: 0
Study: 22228322

Group type: EXPERIMENTAL
Intervention: Treatment for moderate to severe hot flushes
Number of subjects: 710

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 710
Study: 20511018

Group type: EXPERIMENTAL
Intervention: Injectable heroin
Number of subjects: 127

Group type: COMPARATOR
Intervention: Oral methadone
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Injectable methadone
Number of subjects: 127
Study: 18173144

Group type: EXPERIMENTAL
Intervention: Fangchuan Mixture (FCM)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Fangchuan Mixture + Flixotide (Group C)
Number of subjects: 175
Study: 15711601

Group type: EXPERIMENTAL
Intervention: High dairy protein/high-calcium diet (DP, 2400 mg Ca/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: High mixed protein/moderate calcium diet (MP, 500 mg Ca/d)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both diets (DP and MP)
Number of subjects: 50
Study: 11801552

Group type: EXPERIMENTAL
Intervention: Topical DFMO
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 10422932

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2.5 mg with fentanyl 25 microg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Bupivacaine 1.25 mg with fentanyl 25 microg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Plain fentanyl 25 microg
Number of subjects: 90
Study: 7768495

Group type: EXPERIMENTAL
Intervention: 40 mg pravastatin day-1 for 3 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study: 2189394

Group type: EXPERIMENTAL
Intervention: Transcervical chorion villus sampling
Number of subjects: 210

Group type: COMPARATOR
Intervention: Transabdominal chorion villus sampling
Number of subjects: 210
Study: 733132

Group type: EXPERIMENTAL
Intervention: Intravenous penicillin and tetracycline
Number of subjects: 265

Group type: COMPARATOR
Intervention: Intravenous penicillin and intramuscular tobramycin
Number of subjects: 265

Group type: COMPARATOR
Intervention: Intact membranes
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Ruptured membranes for less than 6 hours
Number of subjects: 265
Study: 31523039

Group type: EXPERIMENTAL
Intervention: Dexamethasone (12 mg, two intramuscular injections, 24 hours apart)
Number of subjects: 1346

Group type: COMPARATOR
Intervention: Betamethasone (11.4 mg, two intramuscular injections, 24 hours apart)
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 1346

Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 1346
Study: 28225684

Group type: EXPERIMENTAL
Intervention: MRI at a magnetic field strength of 1.5 tesla
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Repeat MRI
Number of subjects: 1500
Study: 26087318

Group type: EXPERIMENTAL
Intervention: Combined delayed cord clamping and umbilical cord milking
Number of subjects: 300

Group type: COMPARATOR
Intervention: Milking of the cut cord
Number of subjects: 300

Group type: COMPARATOR
Intervention: Delayed cord clamping
Number of subjects: 300
Study: 23297919

Group type: EXPERIMENTAL
Intervention: Linguistic identification training task
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Indexical identification training task
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (passive exposure)
Number of subjects: 60
Study: 21709597

Group type: EXPERIMENTAL
Intervention: Epidural cortical stimulation of the left dorsolateral prefrontal cortex
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 19192350

Group type: EXPERIMENTAL
Intervention: GnRH antagonist (0.25 mg per day) during endometrial priming with oestradiol (group I, n = 49)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (group II, n = 49) receiving only endometrial preparation
Number of subjects: 98
Study: 16783042

Group type: EXPERIMENTAL
Intervention: Omeprazole with alginate
Number of subjects: 26

Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 26
Study: 15235686

Group type: EXPERIMENTAL
Intervention: Warfarin for 24 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard anticoagulation for 6 months
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 11300425

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg once daily
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 9291556

Group type: EXPERIMENTAL
Intervention: Occlusal adjustment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Counselling alone (Control)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Overall treatment (including counselling and occlusal adjustment)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall intensity of pain (measured by visual analogue scale)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Demand for rescue treatment
Number of subjects: 50
Study: 8322777

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg/d)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3539548

Group type: EXPERIMENTAL
Intervention: Regional hyperthermic cytostatic perfusion with Melphalan (42 degrees C) in group B (n = 53)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group A (n = 54) with wide excision of tumors and regional lymph node dissection
Number of subjects: 107
Study: 29631307

Group type: EXPERIMENTAL
Intervention: Individual motivational intervention (HaLT‐Präventionsprojekt) in Group A (n=28)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No intervention in Group B (n=20)
Number of subjects: 48
Study: 28695535

Group type: EXPERIMENTAL
Intervention: Single dose of lurasidone (20, 40, and 80 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Multiple doses of lurasidone (40 mg administered once daily for 5 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 25893562

Group type: EXPERIMENTAL
Intervention: Creatine (CR) supplementation at 20 g day(‐1) during cast-immobilization
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (PLA) during cast-immobilization
Number of subjects: 25
Study: 23911535

Group type: EXPERIMENTAL
Intervention: Basal Bolus regimen with glargine once daily and glulisine before meals
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Basal Plus regimen with glargine once daily and supplemental doses of glulisine before meals
Number of subjects: 298

Group type: COMPARATOR
Intervention: Medicine patients
Number of subjects: 298
Study: 20842759

Group type: EXPERIMENTAL
Intervention: FITT-NH (telephone intervention)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-contact control (standard care)
Number of subjects: 46
Study: 18422590

Group type: EXPERIMENTAL
Intervention: Risedronate (RIS) 35 mg once weekly
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD) 20 microg once daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 44
Study: 16868481

Group type: EXPERIMENTAL
Intervention: Creon 10
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14976882

Group type: EXPERIMENTAL
Intervention: Large dosage of Salvia injection (24 ml)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Middle dosage of Salvia injection (16 ml)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Small dosage of Salvia injection (8 ml)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no Salvia injection)
Number of subjects: 64
Study: 10970081

Group type: EXPERIMENTAL
Intervention: Full thickness skin graft repair
Number of subjects: 68

Group type: COMPARATOR
Intervention: Partial thickness skin graft repair
Number of subjects: 68
Study: 9085056

Group type: EXPERIMENTAL
Intervention: Double gloves
Number of subjects: 400

Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 400
Study: 7871061

Group type: EXPERIMENTAL
Intervention: Brofaromine (150 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3609849

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: D5NS infusion (Control)
Number of subjects: 15
Study: 30701878

Group type: COMPARATOR
Intervention: macitentan 10 mg
Number of subjects: 742

Group type: COMPARATOR
Intervention: macitentan
Number of subjects: 742
Study: 26853501

Group type: EXPERIMENTAL
Intervention: guided meditation
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: music
Number of subjects: 121

Group type: COMPARATOR
Intervention: standard‐care control group
Number of subjects: 121
Study: 25007166

Group type: EXPERIMENTAL
Intervention: Heparin-grafted dialyzer
Number of subjects: 251

Group type: COMPARATOR
Intervention: Standard-of-care (regular saline flushes or pre-dilution)
Number of subjects: 251
Study: 21911257

Group type: COMPARATOR
Intervention: 30 min full spectrum light (9000 lx, 5000 K)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 30 min blue‐enriched light (9000 lx, 17,000 K)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 20 min blue‐enriched light
Number of subjects: 52
Study: 20235450

Group type: EXPERIMENTAL
Intervention: Diplopore puncture of tympanum and intratympanic administration (DPTIA) combined with medication
Number of subjects: 141

Group type: COMPARATOR
Intervention: Haplopore puncture of tympanum combined with medication
Number of subjects: 141
Study: 18672766

Group type: EXPERIMENTAL
Intervention: Modified Wuhua Decoction (WHD) plus oral levocetirizine tablet
Number of subjects: 75

Group type: COMPARATOR
Intervention: Levocetirizine tablet alone
Number of subjects: 75
Study: 16096356

Group type: EXPERIMENTAL
Intervention: Upper extremity disorders (neck, shoulder, hand)
Number of subjects: 17669

Group type: EXPERIMENTAL
Intervention: Job content, physical working condition, interpersonal relationships, organizational problems
Number of subjects: 17669

Group type: EXPERIMENTAL
Intervention: Male workers in manufacturing industries
Number of subjects: 17669

Group type: EXPERIMENTAL
Intervention: Female workers in public administration
Number of subjects: 17669
Study: 11818308

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 0
Study: 11291373

Group type: EXPERIMENTAL
Intervention: Family-directed program featuring mailed booklets and telephone contacts by health educators
Number of subjects: 0

Group type: COMPARATOR
Intervention: No family-directed program (control group)
Number of subjects: 0
Study: 9372530

Group type: EXPERIMENTAL
Intervention: quetiapine (300-700 mg/day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: clozapine (300-600 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: haloperidol (10-20 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 18
Study: 8501142

Group type: EXPERIMENTAL
Intervention: 5 mg alendronate
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 20 mg alendronate
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 40 mg alendronate
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Alendronate (all doses)
Number of subjects: 65
Study: 3687038

Group type: EXPERIMENTAL
Intervention: Canrenon with hydrochlorothiazide (HCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison product available on the market
Number of subjects: 0
Study: 29802965

Group type: EXPERIMENTAL
Intervention: HABITS intervention (habit formation focusing on improving fruits/vegetables, fried foods, sugar-sweetened beverages, physical activity, and self-monitoring)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Existing home visitation services without obesity-related content
Number of subjects: 298
Study: 27931249

Group type: EXPERIMENTAL
Intervention: Culturally and linguistically tailored web-based sleep educational platform for 2 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard sleep health literature
Number of subjects: 200
Study: 24997476

Group type: EXPERIMENTAL
Intervention: Standard dose of 25‐30 minutes of aerobic exercise (STAN)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Higher dose of 50‐60 minutes of aerobic exercise (HIGH)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Higher dose of 50‐60 minutes of combined aerobic and resistance exercise (COMB)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Overall adherence to the supervised exercise sessions
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Demographic, medical, fitness, and quality of life predictors
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Disease stage
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 301
Study: 23077042

Group type: EXPERIMENTAL
Intervention: Pleasant pictures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unpleasant pictures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral pictures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All picture categories
Number of subjects: 0
Study: 20350745

Group type: EXPERIMENTAL
Intervention: Foot gel pads
Number of subjects: 100

Group type: COMPARATOR
Intervention: No foot gel pads
Number of subjects: 100
Study: 18669993

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS) + Treatment as Usual (TAU)
Number of subjects: 41
Study: 15746650

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 14639098

Group type: EXPERIMENTAL
Intervention: Adenosine injection (doses not specified)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 33
Study: 10888041

Group type: EXPERIMENTAL
Intervention: Split-course radiotherapy alone (Group 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy with 6 mg/m2 of cisplatin and split-course radiotherapy (Group 2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sequential chemotherapy with two cycles of etoposide, ifosfamide, and cisplatin followed by split-course radiotherapy (Group 3)
Number of subjects: 45
Study: 8886466

Group type: EXPERIMENTAL
Intervention: Project TRUST
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 1712951

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 28

Group type: COMPARATOR
Intervention: No antiarrhythmic drug therapy
Number of subjects: 28
Study: 31779605

Group type: EXPERIMENTAL
Intervention: Modern contraceptive use
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Family size greater than four
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Family planning counseling service
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Discussing contraceptive issues with sexual partner
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: History of giving birth(s)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: WHO clinical stage III or IV
Number of subjects: 632

Group type: COMPARATOR
Intervention: Older age
Number of subjects: 632

Group type: COMPARATOR
Intervention: Being widowed
Number of subjects: 632
Study: 28685966

Group type: EXPERIMENTAL
Intervention: Web-based educational intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 25382448

Group type: EXPERIMENTAL
Intervention: Toothbrushing + rinsing (0.06% CHX + 0.025% NaF, alcohol-free experimental rinse)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Toothbrushing + rinsing (0.06% CHX + 0.03% CPC + 0.025% NaF, alcohol-free experimental rinse)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Toothbrushing + rinsing (0.06% CHX + 0.025% NaF, alcohol-containing rinse, positive control)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Toothbrushing alone (negative control)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 155
Study: 23720950

Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 0
Study: 21890226

Group type: EXPERIMENTAL
Intervention: Aerobic plus resistance training (ART)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 47